SPEECH-PROCESSING-SOLU
21.6.2016 09:03:13 CEST | Business Wire | Press release
Speech Processing Solutions , the international leader in professional dictation, just launched a new dictation microphone. The improved SpeechMike Premium Touch comes with an innovative touch sensor for optimized and ergonomic navigation, including reduced thumb movement, and an enhanced barcode scanner for quick and easy file association. In addition to these user-friendly updates, the device can scan even more types of bar- and QR codes than its predecessor. The SpeechMike Premium Touch dictation microphone lets healthcare, legal and business professionals dictate their documents, saving them time and resources by allowing them to accomplish their core tasks – benefits that can be directly passed on to their clients.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160621005179/en/
Renowned for its superior microphone quality
The Philips SpeechMike Premium has long been known for its crystal-clear recording quality, and sets the standard for dictation devices worldwide. The free-floating microphone guarantees that almost no background, touch, click, air or structure-borne noise is recorded. “The SpeechMike Premium has established itself as THE benchmark for professional dictation microphones in the industry,” said Dr. Thomas Brauner, CEO of Speech Processing Solutions. “Unrivaled recording quality and noise canceling capabilities, as well as its perfect ergonomics and the antimicrobial surface make it a perfect tool for professional dictation users. These functions are especially helpful for attorneys and medical personnel.”
Focus on content
The new device is equipped with a durable touch sensor. Users can accurately control their mouse cursor using the new SpeechMike Premium Touch. This allows them to easily use and navigate within applications while recording, without having to switch between the mouse and microphone .
Less frequently used functions are placed above or below the sensor, and clearly delineated. Clearly marked distances and different shapes are perfect for operating the device without constantly looking down. Even the Premium Touch’s flip side is optimized for ergonomic and easy use: “Trigger” and “Command” buttons are placed just right to prevent unwanted activation. The key is to focus on content rather than complicated usage instructions. Configurable functions permit a personalized workflow, and an integrated movement sensor that mutes the microphone when not in use adds a finishing touch. “The new features guarantee smooth and convenient operation, even when recording over longer periods of time every day. The Premium Touch can also read more barcodes than its predecessor, allowing end users to quickly categorize and associate client and patient data. The results are enhanced security and potential cost savings,” said Brauner.
Speech to text made easy
Philips SpeechMike Premium Touch makes going from recording your voice to a written document a simple process. The dictation microphone is easy to integrate into users’ IT infrastructures, and works in harmony with existing software, both in large hospitals or small businesses. Thanks to the excellent recording quality, Philips SpeechMike Premium Touch is perfectly suited for transcription, whether by an assistant, speech recognition software, or Philips dictation workflow solutions such as SpeechLive and SpeechExec.
Philips SpeechLive dictation solution
Philips workflow software creates a smooth and safe work cycle between authors and transcriptionists. “Philips SpeechLive is a perfect solution for people like myself, who are on the go a lot. It guarantees a reliable and safe transmission of dictations, regardless of what time it is” explained Dr. Peter Klein, partner at the international law firm PFKA, in Austria adding that: “The offered transcription service is another advantage, particularly in foreign languages such as French, as it virtually increases our office’s capacity.”
For more information on the Philips SpeechMike Premium Touch (SMP3700/3800 series) visit: www.philips.com/dictation
Philips is now offering a free 30-day SpeechLive trial including 10 free transcription minutes at: www.speechlive.com
About Speech Processing Solutions
Speech Processing Solutions is the global number one in professional dictation. Founded in Austria in 1954 as part of Philips, the company has been the driving force in speech-to-text innovations for over 60 years. Always striving for excellence and putting emphasis on outstanding quality, the company has designed groundbreaking products, such as the portable Philips Pocket Memo voice recorder , the Philips SpeechMike Premium dictation microphone and the Philips SpeechExec dictation recorder app for smartphones. The latest innovation, Philips SpeechLive , makes dictation quicker and more convenient than ever before, by bringing secure dictation workflow to the cloud and enabling seamless speech-to-text with the new speech recognition service. With solutions perfectly tailored to individual industry needs, Speech Processing Solutions has helped millions of satisfied customers around the globe save time and resources, allowing them to work as efficiently as possible.
Connect with Speech Processing Solutions on:
Facebook: http://www.facebook.com/philipsvoicetracer
Twitter @speech_com: http://www.twitter.com/speech_com
YouTube: http://www.youtube.com/philipsdictation
LinkedIn: http://www.linkedin.com/company/speech-processing-solutions
View source version on businesswire.com: http://www.businesswire.com/news/home/20160621005179/en/
Contact:
Speech Processing Solutions
Lea Pachta
lea.pachta@speech.com
Tel:
+43 1 60529-1744
www.philips.com/dictation
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati
IAS Launches IAS Total TV Solutions Giving Marketers ‘Linear-like’ Transparency for Connected TV27.4.2026 14:30:00 CEST | Press release
‘IAS Total TV’ unlocks show, genre and rating transparency measurement across Disney, NBCUniversal, Paramount and Prime Video, plus multiple opted-in publishers using Publica enabling advertisers to enhance brand suitability while increasing campaign outcomes Integral Ad Science (IAS) today announced ‘IAS Total TV’, a new comprehensive suite of Connected TV (CTV) solutions designed specifically to bring ‘linear-like’ transparency to streaming TV. IAS Total TV can provide marketers with genre, rating, language, show and program-level data in aggregate from Disney, NBCUniversal, Paramount and Prime Video, in addition to multiple opted-in publishers using Publica. IAS Total TV integrates content insights, media quality, supply path and outcomes into a unified view within the IAS Signal user interface (UI). Advertisers can determine when and how they want their advertising to run alongside CTV content, ensuring brand-related and brand suitable environments. “As advertisers continue to doub
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 14:00:00 CEST | Press release
New Q1 2026 “Agentic Commerce Pulse” survey from Riskified reveals a growing trust gap in agent-driven commerce, as consumers embrace AI across the shopping journey but remain hesitant to hand over control amid concerns over fraud, security, and accountability Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-maki
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 14:00:00 CEST | Press release
90% of dealmakers expect cross-border M&A activity to increase over the next 12–24 months75% cite foreign direct investment screening as the biggest threat to deal completion88% report longer signing-to-close timelines than three years ago Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environ
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 13:43:00 CEST | Press release
For Trade and Medical Media Only The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal-free survival at Day 90 Study showed favourable benefit for toxicity-related discontinuations and drug-drug interactions (DDIs) Rezafungin was well tolerated, with a safety profile comparable to standard antimicrobial regimens (SARs) Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom